Mold-Tek Packaging Earnings Call Transcript: Key Takeaways
Q2 volumes rose 10.1% and profits 36%, with EBITA/kg of ₹46.5. H1 volume growth is only about 8% against a double-digit target, and lubricants fell about 12%.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Q2 volumes rose 10.1% and profits 36%, with EBITA/kg of ₹46.5. H1 volume growth is only about 8% against a double-digit target, and lubricants fell about 12%.
Q2 FY27 revenue Rs274.23 Cr (+31% YoY), PAT Rs21.07 Cr (+36%), EBITDA Rs51.27 Cr (+30%) at 18.70% margin. H1 revenue +28%, PAT +23%.
Mold-Tek delivered record Q1 FY27 revenue exceeding 300 crores, driven by high-margin pharma and food segments. EBITDA/kg hit a record 46.7 despite volume headwinds in lubricants.
Mold-Tek Packaging reported strong Q1 FY27 results with 24.9% revenue growth and 14.2% PAT growth, driven by IML adoption and pharma segment expansion.
Mold-Tek Packaging Q4 FY26 earnings transcript highlights a healthy 13.4% sales growth driven by strong performance in Pharma (+200% for full year) and Food/FMCG segments.
Mold-Tek Packaging is diversifying into pharma and food packaging while navigating stagnant lubricant segment performance through consolidation and margin expansion.
Mold-Tek Packaging Limited reported strong FY26 performance with 13.48% revenue growth and 20.35% PAT growth, driven by IML adoption and pharma expansion.